Table III.
Sample | AEG-1-Abs positive case n (%) in stage I and II | AEG-1-Abs positive case n (%) in stage III and IV | P-value |
---|---|---|---|
Breast cancer | 9 (30) | 35 (51) | 0.049 |
Hepatic carcinoma | 8 (26) | 40 (62) | 0.001 |
Rectal cancer | 6 (30) | 37 (54) | 0.055 |
Lung cancer | 8 (35) | 43 (48) | 0.264 |
Gastric cancer | 9 (39) | 43 (64) | 0.023 |
Total cancer | 40 (31) | 198 (56) | <0.01 |
AEG-1-Abs, anti-AEG-1 auto-antibodies.